Extraintestinal Clostridioides difficile infection
IDCases, 2020 Clostridioides (Clostridium) difficile is the major cause of healthcare antibiotic-associated diarrhoea. However, extra-intestinal manifestations of Clostridioides (Clostridium) difficile infection (CDI) (including bacteremia and tissue infection) are ...
Zhao Hai +6 more
doaj +4 more sources
Non–C. difficile Clostridioides Bacteremia in Intensive Care Patients, France
Emerging Infectious Diseases, 2021 Usually responsible for soft tissue infections, Clostridioides species can also cause bacteremia, life-threatening infections often requiring intensive care unit (ICU) admission.
Guillaume Morel +21 more
doaj +2 more sources
Foodborne Clostridioides Species: Pathogenicity, Virulence and Biocontrol Options
Microorganisms, 2023 Clostridioides species possess many virulence factors and alarming levels of muti-drug resistance which make them a significant risk to public health safety and a causative agent of livestock disease.
Mary Garvey
doaj +2 more sources
Newer Therapeutics to Selectively Kill Clostridioides difficile and Restore the Microbiome [PDF]
Infectious Disease ReportsBackground: The antibiotic ibezapolstat and the live biotherapeutic product live-JSLM are promising future approaches for treating Clostridioides difficile infection.
Guido Granata, Nicola Petrosillo
doaj +2 more sources
Beyond difficile: three novel toxin B-producing Clostridioides species from human patients with diarrhea [PDF]
Emerging Microbes and InfectionsClostridioides difficile infection (CDI), primarily mediated by toxin B (TcdB), is a leading cause of healthcare-associated and community-acquired diarrhea worldwide.
Daniela Aguilar +13 more
doaj +2 more sources
Evaluation of the STANDARD M10 and Xpert C. difficile assays for the detection of toxigenic Clostridioides difficile in stools [PDF]
Microbiology SpectrumThis study aims to compare the sensitivity and specificity of two Nucleic Acid Amplification Tests (NAATs), the STANDARD M10 Clostridioides difficile (M10) and the Xpert C. difficile (Xpert) assays, for the detection of toxigenic C.
Y. Roukoz-Diab +7 more
doaj +2 more sources
Clostridioides difficile Infection [PDF]
RGUHS Journal of Medical Sciences, 2022 In the past decade Clostrdioides difficile has become a leading enteric pathogen causing antibiotic-associated diarrohoea and colitis. The manifestations range from diarrhoea to life-threatening damage to the large intestine. It is noted as a nosocomial and community acquired infection in most of the countries including India.
openaire +2 more sources
Family Medicine & Primary Care ReviewClostridioides difficile infection is the most common cause of antibiotic-associated diarrhea. IDSA/SHEA, ESCMID and ACG updated the clinical practice guidelines for CDI in 2021. This paper is an attempt to summarize these guidelines.
Mateusz Piotr Baran +4 more
doaj +2 more sources
Clostridioides Difficile Enteritis: Case Report and Literature Review
Antibiotics, 2022 Background: Clostridioides Difficile is a well-known pathogen causing diarrhea of various degrees of severity through associated infectious colitis.
Artsiom Klimko +6 more
doaj +2 more sources
Analysis of the impact of secondary prophylaxis on recurrence in critically ill adults
SAGE Open Medicine, 2020 Introduction: Clostridioides (formerly Clostridium ) difficile infection recurrence in patients re-exposed to antibiotics for treatment of a non- Clostridioides difficile infection is high at approximately 33%. Low-dose per os vancomycin (e.g. 125 mg q12
Kathryn A Connor, Kelly M Conn
doaj +2 more sources